細胞解離製品の世界市場の予測 (～2023年)：酵素 (コラゲナーゼ・トリプシン・DNアーゼ・エラスターゼ)・非酵素
Cell Dissociation Market by Product (Enzymatic (Collagenase, Trypsin, DNase, Elastase) Non-enzymatic), Type (Tissue Dissociation), Tissue (Connective, Epithelial), End User (Pharmaceutical, Research Institutes) - Global Forecast to 2023
|出版日||ページ情報||英文 116 Pages
|細胞解離製品の世界市場の予測 (～2023年)：酵素 (コラゲナーゼ・トリプシン・DNアーゼ・エラスターゼ)・非酵素 Cell Dissociation Market by Product (Enzymatic (Collagenase, Trypsin, DNase, Elastase) Non-enzymatic), Type (Tissue Dissociation), Tissue (Connective, Epithelial), End User (Pharmaceutical, Research Institutes) - Global Forecast to 2023|
|出版日: 2018年03月28日||ページ情報: 英文 116 Pages||
世界の細胞解離製品の市場は予測期間中12.8%のCAGR (年間複合成長率) で推移し、2018年の2億4120万米ドルから、2023年には4億4050万米ドルの規模に成長すると予測されています。慢性疾患の研究に対する公的投資の拡大、医薬品・バイオテクノロジー企業によるR&D投資の拡大などの要因が同市場の成長を推進しています。
"The global cell dissociation market is projected to grow at a CAGR of 12.8% during the forecast period"
The cell dissociation market is expected to reach USD 440.5 million by 2023 from USD 241.2 million in 2018, at a CAGR of 12.8%. Factors driving the growth of this market include rising government funding for chronic disease research and increasing R&D investment in pharmaceutical & biotechnology companies. On the other hand, emerging economies such as China, India, and Brazil are providing lucrative opportunities for the players operating in the cell dissociation market.
Based on product, the market is segmented into enzymatic dissociation products, non-enzymatic dissociation products, and instruments & accessories market. Among all, the non-enzymatic product segment is estimated to grow at the highest CAGR during the forecast period. This can be primarily attributed to advantages such as ready to use and non-toxic in nature.
On the basis of type, the market is segmented into tissue dissociation and cell detachment. The tissue dissociation segment dominated the market in 2017. Increasing demand for enzymatic products and instruments & accessories in the pharmaceutical & biotechnology companies is the major driving factor for this segment.
Geographically, the cell dissociation market was dominated by North America, followed by Europe in 2017. However, Asia Pacific is estimated to grow at the fastest rate due to infrastructural developments in the life sciences industry, rising government investments for chronic disease research, and presence of emerging economies such as China and India.
The primary interviews conducted for this report can be categorized as follows:
The key players in the cell dissociation market include: Thermo Fisher Scientific (US), Merck KGaA (Germany), Roche (Switzerland), Miltenyi Biotec (Germany), HiMedia Laboratories (India), STEMCELL Technologies (Canada), BD (US), ATCC (US), PAN-Biotech (Germany), and GE Healthcare (US).
The report analyses the cell dissociation market by product, tissue, type, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles include product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful.
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use one or a combination of the below mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.